Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2019

NEXT STORY
Positive data from Sanifit’s Phase 2b CaLIPSO trial of SNF472 published in Circulation
PREV STORY
Fennec Provides Business Update and Announces Third Quarter 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

First quarter with 2% growth in Swiss francs, 7%[1] at constant exchange rates

author_avatar
NASDAQ Market News

Regenerative Medicine Market Size to Hit US$ 23.7 Bn by 2027

author_avatar
NASDAQ Market News

Worldwide Aminoglycosides Markets, 2019 to 2024: Expiry of Patent Exclusivity has Led to Large Scale Generic Manufacturing of Aminoglycosides, Particularly in the Developing Region of Asia-Pacific

author_avatar
NASDAQ Market News